STOCK TITAN

AIP files Rule 144 to sell 11,841 shares on NASDAQ

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Arteris, Inc. insider notice reports a proposed sale under Rule 144 of 11,841 common shares with an aggregate market value of $130,014.18. The shares were acquired on 01/28/2021 through previously exercised stock options and were paid for in cash. The filing names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker and lists an approximate sale date of 10/06/2025 on NASDAQ. The notice also discloses a prior sale on 08/05/2025 of 6,909 shares generating $97,699.48, and includes the standard Rule 10b5-1 representation and signature attestation.

Positive

  • 11,841 shares identified for sale were acquired on 01/28/2021 via previously exercised stock options
  • Proposed sale lists a named institutional broker: Morgan Stanley Smith Barney LLC
  • Filer included prior sale detail: 6,909 shares sold on 08/05/2025 for $97,699.48, showing transaction transparency

Negative

  • Proposed insider sale of 11,841 shares with market value $130,014.18 may be viewed unfavorably by some investors
  • Recent sale activity ( 6,909 shares on 08/05/2025 ) indicates ongoing insider liquidity events

Insights

Small scheduled insider sale from exercised options; shows planned liquidity, not new issuance.

The filing documents a proposed Rule 144 sale of 11,841 common shares acquired via previously exercised stock options on 01/28/2021, indicating the shares are not newly issued but derived from an earlier compensation event. The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services and the sale is tentatively dated 10/06/2025.

Key dependencies include timing of execution and whether the seller relies on a 10b5-1 plan; the form contains the usual attestation about material nonpublic information. Watch for an actual Form 4 or trade report shortly after 10/06/2025 to confirm execution and proceeds.

Filing follows Rule 144 mechanics and includes prior 10b5-1 sales disclosure.

The notice lists acquisition details, purchase consideration (cash), and prior sales including a 08/05/2025 trade of 6,909 shares for $97,699.48, meeting disclosure expectations under Rule 144. The seller makes the required representation about material nonpublic information.

Compliance attention should focus on any accompanying 10b5-1 plan dates and subsequent public filings showing actual sales; those items will clarify whether the transactions were preplanned or discretionary within the near term.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Arteris (AIP) disclose in this Form 144?

The filing reports a proposed Rule 144 sale of 11,841 common shares valued at $130,014.18, to be sold approximately on 10/06/2025, acquired via exercised options on 01/28/2021.

Who is the broker handling the proposed sale for AIP?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY.

Were any shares of Arteris sold recently by the same account?

Yes. The filing shows a prior sale on 08/05/2025 of 6,909 shares, generating $97,699.48 in gross proceeds.

How were the shares acquired that are now proposed for sale?

The shares were acquired on 01/28/2021 through previously exercised stock options, and payment was made in cash.

Does the filing state whether a 10b5-1 trading plan is in effect?

The form includes the standard 10b5-1 attestation area, but no specific plan adoption date is provided in the visible content.
Arteris, Inc.

NASDAQ:AIP

AIP Rankings

AIP Latest News

AIP Latest SEC Filings

AIP Stock Data

718.16M
31.36M
30.11%
47.91%
3.85%
Semiconductors
Semiconductors & Related Devices
Link
United States
CAMPBELL